Literature DB >> 24706944

BENEFIT 8-year results provide further support for the long-term value of early treatment of multiple sclerosis.

K Fujihara.   

Abstract

Entities:  

Keywords:  Multiple Sclerosis

Mesh：

Substances：

Year:  2014        PMID： 24706944     DOI： 10.1136/jnnp-2013-306720

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  2 in total

1.  Apelin-13: A Promising Biomarker for Multiple Sclerosis?

Authors:  Murat Alpua; Yakup Turkel; Ersel Dag; Ucler Kisa
Journal:  Ann Indian Acad Neurol       Date:  2018 Apr-Jun       Impact factor: 1.383

2.  Disability Progression in Multiple Sclerosis Patients using Early First-line Treatments.

Authors:  Mathilde Lefort; Sandra Vukusic; Romain Casey; Gilles Edan; Emmanuelle Leray
Journal:  Eur J Neurol       Date:  2022-05-26       Impact factor: 6.288
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.